MedTrace Logo

Multimodal Prehabilitation to Enhance Functional Recovery After Lung Surgery

NCT02938104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-03-22

No results posted yet for this study

Summary

The investigators propose a randomized controlled study in patients undergoing lung resection for cancer to compare the impact of multimodal intervention composed of exercise, nutritional supplement and psychological well-being on functional exercise capacity. One group (rehabilitation group) will receive the multimodal intervention after surgery for 8 weeks; the other will start 4 weeks before surgery and continue for 8 weeks postop (prehabilitation group). In this case, both groups will be exposed to the program, which will be available to both groups postoperatively. One of the two groups will start this program 4 weeks before surgery and continue for 8 weeks postoperatively, and the other will start once they leave the hospital and continue for 8 weeks postoperatively.

Conditions

Interventions

DIETARY_SUPPLEMENT

Whey Protein Isolate Powder

Nutritional counselling is given to patients to ensure their daily proteins and energy requirements are met. Whey Protein Isolate Posder (Immunocal) is provided. Immunocal (1.5g/kg PO (by mouth) per day in daily doses

BEHAVIORAL

Physical Exercise Program

Physical exercises personalized by a kinesiologist consisting of walking or stationary bike and elastic band exercises.

BEHAVIORAL

Relaxation Techniques

Relaxation techniques consisting of breathing exercises and using a relaxation CD

Sponsors & Collaborators

  • Immunotec Inc.

    collaborator INDUSTRY

  • Franco Carli

    lead OTHER

Principal Investigators

  • Franco Carli, MD · Montreal General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02938104 on ClinicalTrials.gov